Sector: HealthcareIndustry: Diagnostics & research
Agilent Technologies Inc
Current Price
Analyst Sentiment
17 ratings: Buy
Strong Buy
1
Buy
8
Hold
8
Sell
0
Strong Sell
0
Agilent Technologies, Inc. is a leading American firm based in Santa Clara, California, that specializes in analytical instrumentation and life sciences solutions. The company is recognized for its innovative offerings t...|
Overview
Market Cap$42.19B
52W High / Low$160 / $96
P/E32.63
PEG2.34
Book Value$23.82
Dividend/Share$0.99
Dividend Yield0.67%
EPS$4.56
Revenue/Share$24.46
OPM23.80%
NPM18.80%
ROA7.52%
ROE20.60%
Gross Profit$3.64B
Forward PE24.81
Price to Sales6.07
Price to Book6.30
EV to Sales6.34
EV to EBITDA24.01
Beta1.28
50D Moving Avg$142.76
200D Moving Avg$123.74
Institutional Holding92.50%
Insider Holding32.10%
Trailing P/E32.63
Qtr EPS Growth24.90%
Qtr Revenue Growth9.40%
Add ratio to table
e.g. Promoter holding
Loading price data...
Earnings Estimates
Analyst consensus EPS and Revenue forecasts.
| Metric (B) | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | FY 2027 |
|---|---|---|---|---|---|---|
EPS Estimate (avg) | $5.01 | $5.41 | $5.24 | $5.57 | $5.95 | $6.56 |
Revenue Estimate (avg) | 6.76 | 6.82 | 6.48 | 6.92 | 7.35 | 7.81 |
EPS Revision (30d avg) | -1.2% | -0.2% | +0.0% | +0.0% | -1.2% | -1.3% |
Peer Comparison
Showing 5 peers (Same Industry)
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | IQVIA Holdings Inc | IQV | $38.42B | 31.04 | 6.32 | 8.07% | 14.00% | 19.40% | 5.20% |
| 2. | Laboratory Corp Of America Holdings | LH | $22.10B | 26.25 | 2.55 | 6.21% | 11.30% | 10.10% | 8.60% |
| 3. | Illumina Inc | ILMN | $19.60B | 28.66 | 8.26 | 16.40% | 21.40% | 31.20% | 0.40% |
| 4. | Icon Plc | ICLR | $14.24B | 24.68 | 1.51 | 7.40% | 12.70% | 6.27% | 0.60% |
| 5. | Quest Diagnostics Inc | DGX | $20.41B | 21.40 | 2.82 | 8.93% | 14.90% | 14.30% | 13.20% |
Quarterly Results
Consolidated Figures in Millions / View Standalone.
View:
| Quarter (M) | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 | Dec 25 |
|---|---|---|---|---|---|---|---|---|
Sales | 1,658 | 1,573 | 1,578 | 1,701 | 1,681 | 1,668 | 1,738 | 1,861 |
Expenses | 524 | 493 | 522 | 508 | 523 | 566 | 554 | 521 |
Operating Profit | 425 | 373 | 365 | 433 | 395 | 289 | 394 | 469 |
OPM % | 25.63% | 23.71% | 23.13% | 25.46% | 23.5% | 17.33% | 22.67% | 25.2% |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest | -4 | -1 | -3 | -8 | -13 | -15 | -12 | 0 |
Depreciation | 62 | 63 | 63 | 69 | 72 | 73 | 72 | 71 |
Profit Before Tax | 403 | 374 | 343 | 401 | 367 | 260 | 366 | 442 |
Tax % | 13.65% | 17.65% | 17.78% | 12.47% | 13.35% | 17.31% | 8.2% | 1.81% |
Net Profit | 348 | 308 | 282 | 351 | 318 | 215 | 336 | 434 |
EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit & Loss
Consolidated Figures in Millions / View Standalone.
View:
| Period (M) | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Sales | 4,202 | 4,472 | 4,914 | 5,163 | 5,339 | 6,319 | 6,848 | 6,833 | 6,510 | 6,948 |
COGS | 2,005 | 2,063 | 2,227 | 2,358 | 2,502 | 2,912 | 3,126 | 3,368 | 2,975 | 3,305 |
Gross Profit | 2,197 | 2,409 | 2,687 | 2,805 | 2,837 | 3,407 | 3,722 | 3,465 | 3,535 | 3,643 |
Gross Profit % | 52.28% | 53.87% | 54.68% | 54.33% | 53.14% | 53.92% | 54.35% | 50.71% | 54.3% | 52.43% |
Operating Exp | 1,582 | 1,568 | 1,776 | 1,864 | 1,991 | 2,060 | 2,104 | 2,115 | 2,047 | 2,164 |
EBITDA | 863 | 1,096 | 1,231 | 1,231 | 1,228 | 1,762 | 1,905 | 1,703 | 1,874 | 1,835 |
Other Income | 1 | 41 | 93 | 52 | 74 | 94 | -30 | 0 | 0 | 0 |
Interest | -2 | -57 | -37 | -38 | -8 | -2 | -75 | -44 | -16 | -112 |
Depreciation | 247 | 214 | 210 | 238 | 308 | 321 | 317 | 271 | 257 | 288 |
Profit Before Tax | 544 | 803 | 946 | 919 | 842 | 1,360 | 1,504 | 1,339 | 1,521 | 1,435 |
Tax Rate % | 15.07% | 14.82% | 66.6% | -16.54% | 14.61% | 11.03% | 16.62% | 7.39% | 15.25% | 9.2% |
Net Profit | 460 | 684 | 316 | 1,071 | 719 | 1,210 | 1,254 | 1,240 | 1,289 | 1,303 |
Balance Sheet
Consolidated Figures in Millions / View Standalone.
View:
| Period (M) | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash & Bank | 2,289 | 2,678 | 2,247 | 1,382 | 1,441 | 1,484 | 1,053 | 1,590 | 1,329 | 1,789 |
Investments | 135 | 138 | 68 | 102 | 316 | 276 | 195 | 164 | 175 | 0 |
Fixed Assets | 639 | 757 | 822 | 850 | 845 | 945 | 1,100 | 1,424 | 1,955 | 0 |
Current Assets | 1,346 | 1,491 | 1,601 | 1,807 | 1,974 | 2,224 | 2,725 | 2,596 | 2,630 | 2,805 |
Other Assets | 3,408 | 3,362 | 3,803 | 5,311 | 5,051 | 5,776 | 5,459 | 4,989 | 5,757 | 8,133 |
Total Assets | 7,817 | 8,426 | 8,541 | 9,452 | 9,627 | 10,705 | 10,532 | 10,763 | 11,846 | 12,727 |
Equity Capital | -10,502 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Reserves | 14,743 | 4,823 | 4,564 | 4,745 | 4,870 | 5,386 | 5,302 | 5,842 | 5,895 | 6,738 |
Borrowing/Debt | 1,912 | 2,011 | 1,799 | 2,407 | 2,359 | 2,781 | 2,769 | 2,781 | 3,574 | 3,354 |
Current Liabilities | 676 | 762 | 847 | 1,128 | 1,006 | 1,215 | 1,364 | 1,052 | 1,264 | 1,419 |
Other Liabilities | 985 | 818 | 1,324 | 1,169 | 1,389 | 1,320 | 1,094 | 1,085 | 1,110 | 1,213 |
Total Liabilities & Equity | 7,814 | 8,417 | 8,537 | 9,452 | 9,627 | 10,705 | 10,532 | 10,763 | 11,846 | 12,727 |
Cash Flow Statement
Consolidated Figures in Millions / View Standalone.
View:
| Period (M) | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating | 793 | 889 | 1,087 | 1,021 | 921 | 1,485 | 1,312 | 1,772 | 1,751 | 1,559 |
Cash Flow from Investing | -238 | -305 | -704 | -1,590 | -147 | -749 | -338 | -310 | -1,258 | -394 |
Cash Flow from Financing | -268 | -202 | -797 | -299 | -717 | -696 | -1,372 | -930 | -752 | -715 |
Net Cash Flow | 286 | 389 | -431 | -866 | 59 | 43 | -398 | 0 | 0 | 0 |